Emergent Biosolutions Inc

NYSE:EBS   3:59:59 PM EDT
96.11
-1.54 (-1.58%)
Products, Regulatory

Emergent's COVID-19 HIG Product Candidate To Be Included In NIH-Sponsored Trial To Treat COVID-19

Published: 10/08/2020 22:10 GMT
Emergent BioSolutions Inc (EBS) - Emergent Biosolutions’ Covid-19 Human Immune Globulin Product Candidate to Be Included in Nih-sponsored Phase 3 Clinical Trial of Hyperimmune Intravenous Immunoglobulin to Treat Covid-19.
Emergent Biosolutions - Planning More Trials to Evaluate Covid-hig for Potential Use in Other Patient Populations/individuals at High Exposure Risk.